Evolent Health, Inc. (NYSE:EVH) Q4 2023 Earnings Call Transcript

Seth Blackley: Yes, Jack look, I think we are already seeing some of that opportunity come to bear fruit for us. We’ve been — it’s been about a year since we closed the NIA transaction, and we’ve seen several cross-sells that we’ve announced. And so, I think we’re in that zone now where those opportunities are paying off. It often takes, if you get into one of those conversations, I’ll call it six months to have a sales cycle around it. And again, it could be a legacy NIA client, or a legacy Evolent client, it could go in either direction, but it is bearing fruit now.

Jack Wallace: Excellent. Thanks. And then, really we haven’t talked about as much, but the cases business, revenue per case, and they pick-up a bit more fourth quarter, A, what was driving that? And B, you think that it’s going to be persistent going forward? Thank you.

John Johnson: Had a tough time understanding you there, Jack.

Seth Blackley: Jack, could you repeat what you just said? There is an echo.

Jack Wallace: Yes. Apologies, I’m in an airport, I was wondering about the cases business. It looked like revenue per cases was up a little bit in the fourth quarter, I mean if there’s anything structurally going on there that would persist going forward or just timing of activity in the quarter? Thank you.

Seth Blackley: Yes. Nothing particularly structural. There’s a seasonal component and also just regular organic growth.

Jack Wallace: Excellent. Thank you.

Operator: Thank you. [Operator Instructions]. All right. This does conclude the question-and-answer session. I would like to return the floor back to Seth Frank for any closing comments.

Seth Frank: Great. Thanks for joining tonight and look forward to connecting with you offline. Have a good evening.

Operator: Thank you. The conference has now concluded. Thank you for attending today’s presentation. And we now disconnect your lines.